ECSP982801A - COMPOSITION FOR TREATING RESPIRATORY AND SKIN DISEASES - Google Patents
COMPOSITION FOR TREATING RESPIRATORY AND SKIN DISEASESInfo
- Publication number
- ECSP982801A ECSP982801A ECSP982801A ECSP982801A EC SP982801 A ECSP982801 A EC SP982801A EC SP982801 A ECSP982801 A EC SP982801A EC SP982801 A ECSP982801 A EC SP982801A
- Authority
- EC
- Ecuador
- Prior art keywords
- phenyl
- montelukast
- inflammation
- propyl
- hydroxy
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una composición farmacéutica útil para el tratamiento del estornudo, picazón y goteo de la nariz, congestión nasal, enrojecimiento de los ojos, lagrimeo, picazón en los oidos o paladar, brevedad de la respiración, inflamación de la mucosa bronquil, volumen expiatorio forzado en un segundo (FEV), reducido, tos, erupción picazón en la piel, dolores de cabeza y dolores persistentes y dolores asociados con la rinitis alérgica, rinitis alérgica permanente, resfrios comunes, otitis, sinusitis, alergia, asma, asma alérgico y/o inflamación, en un organismo de mamífero que necesita este tratamiento. La composición comprende: i) una cantidad efectiva de al menos un antagonista de leucotrieno seleccionado de g) montelukast h) ácido 1-(((R)(3-(2-(6,7-difluoro 2-quinolinil)etenl)fenil)-2-(2-hidroxi 2-propil)fenil) metilcilopropanoacético; i) ácido 1-(((1(R)-3(3-2-(2,3-diclorotiene(3,2)piridin-5-il)-(E)-etenil)fenil-2-(2-(1hidroxi-1-metil-fenil)propil)tio)metil)ciclopropanoacético;j) pranlukast; o k) zafirtukast, o l) ácido (2-((2--ter-butil -2tiazoli-)-5benzofuranil)oximetil)fenil) acético, o su sal farmacéuticamente aceptable, mezclado con ii) una cantidad efectiva de al menos una anthhistamina que es desacarboetoxiloratidina, cetirizina, fexofenadina, ebastina, astemizol, norastemizol, epinastina, efletirizina o su sal farmacéuticamente aceptable. g) montelukast.A pharmaceutical composition useful for the treatment of sneezing, itching and runny nose, nasal congestion, red eyes, tearing, itchy ears or palate, shortness of breath, inflammation of the bronchial mucosa, forced expiatory volume in a second (FEV), reduced, cough, itchy rash, persistent headaches and aches and pains associated with allergic rhinitis, permanent allergic rhinitis, common colds, otitis, sinusitis, allergy, asthma, allergic asthma and / or inflammation , in a mammalian organism that needs this treatment. The composition comprises: i) an effective amount of at least one leukotriene antagonist selected from g) montelukast h) 1 - (((R) (3- (2- (6,7-difluoro 2-quinolinyl) etenl) phenyl acid ) -2- (2-hydroxy 2-propyl) phenyl) methylcylpropanoacetic; i) 1 - (((1 (R) -3 (3-2- (2,3-dichlorotiene (3,2) pyridin-5- yl) - (E) -ethenyl) phenyl-2- (2- (1-hydroxy-1-methyl-phenyl) propyl) thio) methyl) cyclopropanoacetic; j) pranlukast; ok) zafirtukast, ol) (2 - ((2-tert-butyl -2thiazoli -) - 5benzofuranyl) oxymethyl) phenyl) acetic acid, or its pharmaceutically acceptable salt, mixed with ii) an effective amount of at least one anthhistamine that It is desacarboethoxyloratidine, cetirizine, fexofenadine, ebastine, astemizole, norastemizole, epinastine, efletirizine or its pharmaceutically acceptable salt. g) montelukast.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982801 ECSP982801A (en) | 1998-12-21 | 1998-12-21 | COMPOSITION FOR TREATING RESPIRATORY AND SKIN DISEASES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP982801 ECSP982801A (en) | 1998-12-21 | 1998-12-21 | COMPOSITION FOR TREATING RESPIRATORY AND SKIN DISEASES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP982801A true ECSP982801A (en) | 1999-05-17 |
Family
ID=42043718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP982801 ECSP982801A (en) | 1998-12-21 | 1998-12-21 | COMPOSITION FOR TREATING RESPIRATORY AND SKIN DISEASES |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP982801A (en) |
-
1998
- 1998-12-21 EC ECSP982801 patent/ECSP982801A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4980868A1 (en) | COMPOSITION FOR TREATING RESPIRATORY AND SKIN DISEASES | |
| Zhang et al. | Silybin attenuates LPS-induced lung injury in mice by inhibiting NF-κB signaling and NLRP3 activation | |
| RU2607892C2 (en) | Composition based on xylitol, preventing separation of slime and related methods and compositions | |
| ES2773142T3 (en) | New treatment | |
| US20040204471A1 (en) | Treatment and prevention of otic disorders with Cox-2 inhibitors alone or in combination with otic agents | |
| ATE311174T1 (en) | AQUEOUS COMPOSITIONS CONTAINING CORTICOSTEROIDS FOR NASAL OR PULMONARY ADMINISTRATION | |
| WO2003020219B1 (en) | Aerosolized decongestants for the treatment of sinusitis | |
| AR054411A1 (en) | PHARMACEUTICAL COMBINATION THAT INCLUDES AN OLEFINAL COMPOUND OF 8- AZONIABICICLO [3.2.1] OCTANO AND ONE OR MORE THAN AVAILABLE THERAPEUTIC INGREDIENTS, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS AND USING THOSE COMPONENTS TO PREPARE IT | |
| AR048343A1 (en) | THERAPEUTIC AGENTS FOR THE TREATMENT OF MIGRANA | |
| WO2004043470A1 (en) | The use of an anti-allergy agent and a steroid to treat allergic rhinitis | |
| JP2001526232A5 (en) | ||
| RU2007138270A (en) | The combination of anticholinergics and antagonists of leukotriene receptors for the treatment of respiratory diseases and a pharmaceutical composition based on it | |
| PE20091392A1 (en) | PHARMACEUTICAL COMPOSITIONS AS ANTI-INFLAMMATORY AGENTS | |
| WO2003101434A3 (en) | Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor | |
| CZ248798A3 (en) | Pharmaceutical preparation | |
| BR9914158A (en) | Antibiotic composition for the treatment of eyes, ears and nose | |
| Park et al. | Protective effect of corticosteroid against the cytotoxicity of aminoglycoside otic drops on isolated cochlear outer hair cells | |
| ES2848977T5 (en) | Methods of treating eye conditions | |
| JP2006506414A5 (en) | ||
| Huang et al. | Is a diluted seawater-based solution safe and effective on human nasal epithelium? | |
| Stoelzel et al. | Safety and efficacy of N asya/P revalin in reducing symptoms of allergic rhinitis | |
| ECSP982801A (en) | COMPOSITION FOR TREATING RESPIRATORY AND SKIN DISEASES | |
| MX2009008548A (en) | Olopatadine formulations for topical nasal administration. | |
| Dundar et al. | A safety investigation into topical effects of naproxen sodium on nasal epithelial cells and potential toxicity in local application | |
| Horak et al. | Decongestant activity of desloratadine in controlled-allergen-exposure trials |